117 related articles for article (PubMed ID: 37905439)
1.
Wu HT; Wu Z; Hou YY; Fang ZX; Wu BX; Deng Y; Cui YK; Liu J
Epigenomics; 2023 Sep; 15(18):911-925. PubMed ID: 37905439
[No Abstract] [Full Text] [Related]
2. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.
Yoshida T; Eguchi H; Nakachi K; Tanimoto K; Higashi Y; Suemasu K; Iino Y; Morishita Y; Hayashi S
Carcinogenesis; 2000 Dec; 21(12):2193-201. PubMed ID: 11133808
[TBL] [Abstract][Full Text] [Related]
3. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR
Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993
[TBL] [Abstract][Full Text] [Related]
4. SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells.
Tang X; Yang Y; Song X; Liu X; Wang X; Huang F; Li Y; Chen F; Wan H
Biochem Biophys Res Commun; 2019 Aug; 516(3):851-857. PubMed ID: 31266633
[TBL] [Abstract][Full Text] [Related]
5. Large-scale analysis of
Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
[TBL] [Abstract][Full Text] [Related]
6. IGF2BP3‑stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells.
Han J; Hu X
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616130
[TBL] [Abstract][Full Text] [Related]
7. Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer.
Di Cello F; Cope L; Li H; Jeschke J; Wang W; Baylin SB; Zahnow CA
PLoS One; 2013; 8(7):e68630. PubMed ID: 23844228
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between the methylation status of Runx3 gene and positive expression of estrogen receptor in breast cancer].
Yan Z; Gao S; Wu X; Liu H
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):240-4. PubMed ID: 25975905
[TBL] [Abstract][Full Text] [Related]
9. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
10. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
[TBL] [Abstract][Full Text] [Related]
11. GPER Promoter Methylation Controls GPER Expression in Breast Cancer Patients.
Weissenborn C; Ignatov T; Nass N; Kalinski T; Dan Costa S; Zenclussen AC; Ignatov A
Cancer Invest; 2017 Feb; 35(2):100-107. PubMed ID: 28118074
[TBL] [Abstract][Full Text] [Related]
12. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
13. Slc12a2 is a direct target of two closely related homeobox proteins, Six1 and Six4.
Ando Z; Sato S; Ikeda K; Kawakami K
FEBS J; 2005 Jun; 272(12):3026-41. PubMed ID: 15955062
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the promoter region of bovine SIX4: Roles of E-box and MyoD in the regulation of basal transcription.
Wei D; Feng L; Zhang W; Ma X; Cheng G; Li S; Wang L; Zhang S; Hong J; Guo H; Wang Y; Ning Y; Zan L
Biochem Biophys Res Commun; 2018 Jan; 496(1):44-50. PubMed ID: 29307818
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer.
Rodriguez BA; Cheng AS; Yan PS; Potter D; Agosto-Perez FJ; Shapiro CL; Huang TH
Carcinogenesis; 2008 Jul; 29(7):1459-65. PubMed ID: 18499701
[TBL] [Abstract][Full Text] [Related]
16. SIX4 activates Akt and promotes tumor angiogenesis.
Sun X; Hu F; Hou Z; Chen Q; Lan J; Luo X; Wang G; Hu J; Cao Z
Exp Cell Res; 2019 Oct; 383(1):111495. PubMed ID: 31301290
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
[TBL] [Abstract][Full Text] [Related]
18. Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer.
Wang Y; Gong X; Zhang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34406386
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer.
Fang ZX; Li CL; Wu Z; Hou YY; Wu HT; Liu J
World J Gastrointest Oncol; 2022 Nov; 14(11):2138-2156. PubMed ID: 36438701
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.
Sunami E; Shinozaki M; Sim MS; Nguyen SL; Vu AT; Giuliano AE; Hoon DS
Breast Cancer Res; 2008; 10(3):R46. PubMed ID: 18485221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
